Clinical Trial Update: Study Of Pharmacokinetic (PK) Profile of Bazedoxifene (BZA) in 2 BZA/Conjugated Estrogen Forms [Phase 1]

View source ↗

Summary

A Phase 1 pharmacokinetic study evaluating Bazedoxifene in two Bazedoxifene/conjugated estrogen formulations in postmenopausal women; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopause

Drugs mentioned

• Bazedoxifene (bazedoxifene)
• Conjugated Estrogens (ESTROGENS, CONJUGATED)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Postmenopause | Phase 1 | Status: COMPLETED